- Home
- GTIM vs APM Comparison
GTIM vs APM Comparison
Compare GTIM & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTIM
- APM
- Stock Information
- Founded
- GTIM 1987
- APM 2010
- Country
- GTIM United States
- APM United Kingdom
- Employees
- GTIM N/A
- APM N/A
- Industry
- GTIM Restaurants
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- GTIM Consumer Discretionary
- APM Health Care
- Exchange
- GTIM Nasdaq
- APM Nasdaq
- Market Cap
- GTIM 17.1M
- APM 18.9M
- IPO Year
- GTIM 1990
- APM 2018
- Fundamental
- Price
- GTIM $1.38
- APM $1.40
- Analyst Decision
- GTIM
- APM
- Analyst Count
- GTIM 0
- APM 0
- Target Price
- GTIM N/A
- APM N/A
- AVG Volume (30 Days)
- GTIM 207.1K
- APM 207.6K
- Earning Date
- GTIM 12-11-2025
- APM 12-19-2025
- Dividend Yield
- GTIM N/A
- APM N/A
- EPS Growth
- GTIM 17.03
- APM N/A
- EPS
- GTIM 0.12
- APM N/A
- Revenue
- GTIM $143,398,000.00
- APM N/A
- Revenue This Year
- GTIM N/A
- APM N/A
- Revenue Next Year
- GTIM N/A
- APM N/A
- P/E Ratio
- GTIM $11.36
- APM N/A
- Revenue Growth
- GTIM 1.78
- APM N/A
- 52 Week Low
- GTIM $1.24
- APM $0.46
- 52 Week High
- GTIM $2.90
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- GTIM 38.92
- APM 37.80
- Support Level
- GTIM $1.24
- APM $1.43
- Resistance Level
- GTIM $2.09
- APM $1.50
- Average True Range (ATR)
- GTIM 0.15
- APM 0.09
- MACD
- GTIM -0.03
- APM -0.01
- Stochastic Oscillator
- GTIM 12.35
- APM 9.87
About GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.